Israeli researchers use novel methods to seek treatments for deadly pancreatic cancer
Aviad Weissman
Dr. Oren Parnas of Jerusalem s Hebrew University is profiling individual pancreatic cancer cells from early stage tumors in a bid to discover markers for early diagnosis.
By the time Barbara Goodman was diagnosed with Stage IV pancreatic cancer in October 2001, there were already 30 tumors in her liver. We knew we were in for a pretty tough battle, recalled her husband, Kenneth Goodman, then president of New York-based Forest Laboratories, a pharmaceutical company. But I had an entire research organization I could draw upon.
Nevertheless, nine months after her diagnosis, Barbara died. She was only 51, far younger than usual for pancreatic cancer patients, who are diagnosed, on average, at 70.
Israeli researchers use novel methods to seek treatments for deadly pancreatic cancer jewishledger.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from jewishledger.com Daily Mail and Mail on Sunday newspapers.
In his wife’s memory, Kenneth Goodman established the Barbara S. Goodman Endowed Research Career Development Award for Pancreatic Cancer at the Israel Cancer Research Fund, which supports scientific research in Israel with funds raised in North America.
Jewish Ledger
David Abramson named president of Israel Cancer Research Fund
NEW YORK, New York – David Abramson has been named president of Israel Cancer Research Fund, the largest non-profit dedicated to funding cancer research in Israel, effective Jan. 15, 2021. He succeeds Rob Densen who held this position for two two-year terms.
Abramson, a resident of Chicago, Illinois, is chairman of Rapid Displays, a leading marketing and point-of-purchase display firm. He previously served as CEO of the company for two decades before it was acquired in 2019 by Gemspring Capital. In the early 2000s, he was the chairman of Point of Purchase International, a global non-profit organization, representing 1,800 member companies. He holds an MBA from Northwestern Kellogg School of Business and a BBA from the University of Michigan.
Israeli researchers use novel methods to seek treatments for deadly pancreatic cancer January 11, 2021 2:03 pm Dr. Ziv Gil of the Technion and Rambam hospital in Haifa, is researching the cellular mechanisms underlying the spread, or metastasis, of pancreatic cancer cells. (Pioter Flite)
Advertisement
By the time Barbara Goodman was diagnosed with Stage IV pancreatic cancer in October 2001, there were already 30 tumors in her liver.
“We knew we were in for a pretty tough battle,” recalled her husband, Kenneth Goodman, then president of New York-based Forest Laboratories, a pharmaceutical company. “But I had an entire research organization I could draw upon.”
Nevertheless, nine months after her diagnosis, Barbara died. She was only 51, far younger than usual for pancreatic cancer patients, who are diagnosed, on average, at 70.